LEADER 02755nam  2200601Ia 450 
001 9910458188503321
005 20200520144314.0
010   $a1-282-78742-X
010   $a9786612787423
010   $a0-309-15130-9
035   $a(CKB)2560000000015980
035   $a(EBL)3378636
035   $a(SSID)ssj0000417279
035   $a(PQKBManifestationID)11267613
035   $a(PQKBTitleCode)TC0000417279
035   $a(PQKBWorkID)10361258
035   $a(PQKB)10448333
035   $a(MiAaPQ)EBC3378636
035   $a(Au-PeEL)EBL3378636
035   $a(CaPaEBR)ebr10405099
035   $a(CaONFJC)MIL278742
035   $a(OCoLC)923281847
035   $a(EXLCZ)992560000000015980
100   $a20100511d2010      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aEvaluation of biomarkers and surrogate endpoints in chronic disease$b[electronic resource] /$fCommittee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors
210   $aWashington, DC $cNational Academies Press$dc2010
215   $a1 online resource (335 p.)
300   $aDescription based upon print version of record.
311   $a0-309-15129-5 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Boxes, Figures, and Tables""; ""Summary""; ""1 Introduction""; ""2 Review: Evaluating and Regulating Biomarker Use""; ""3 The Biomarker Evaluation Process""; ""4 Case Studies""; ""5 Strengthening Evidence-Based Regulation""; ""Acronyms""; ""Glossary""; ""Appendix A: Table of Papers About Biomarker Qualification""; ""Appendix B: Recommendations from Related IOM Reports""; ""Appendix C: Committee Member and Consultant Biographies""; ""Appendix D: Staff Biographies""; ""Appendix E: Workshop Agenda""
327   $a""Appendix F: Speaker Biographies""
606   $aBiochemical markers$xEvaluation
606   $aChronic diseases
608   $aElectronic books.
615  0$aBiochemical markers$xEvaluation.
615  0$aChronic diseases.
676   $a610.28
701   $aMicheel$b Christine$0870814
701   $aBall$b John$f1944-$0955362
712 02$aInstitute of Medicine (U.S.).$bCommittee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910458188503321
996   $aEvaluation of biomarkers and surrogate endpoints in chronic disease$92161548
997   $aUNINA